Gregory A. Odle serves as President of Scoliosis at OrthoPediatrics Corp., a leading global provider of pediatric orthopedic solutions. With over 25 years of experience in the medical device industry, Odle has built a distinguished career focused on spinal and orthopedic innovations. Prior to joining OrthoPediatrics in 2018, he held senior leadership roles at Zimmer Biomet, where he spearheaded the commercialization of advanced spinal deformity systems and drove significant revenue growth in the deformity correction segment. His expertise in strategic market expansion and product development has positioned him as a key architect of scoliosis treatment advancements. Under Odle's leadership, the Scoliosis division at OrthoPediatrics has achieved remarkable milestones, including the successful U.S. launch of the ApiFix system—a minimally invasive alternative to traditional spinal fusion for adolescent idiopathic scoliosis—and the expansion of the Aprtex rotation correction system internationally. These initiatives have expanded market access, improved patient outcomes, and contributed to the company's position as a market leader in non-fusion scoliosis technologies. Odle's strategic vision has fostered partnerships with top pediatric spine surgeons worldwide, resulting in double-digit annual growth and enhanced clinical adoption. Odle holds a Bachelor of Science in Business Administration from Indiana University and an MBA from the Kelley School of Business. Passionate about pediatric orthopedics, he remains committed to innovating solutions that prioritize motion preservation and quality of life for young patients with spinal deformities, while guiding OrthoPediatrics' Scoliosis portfolio toward sustained global leadership.